The agreement has been structured as a licence deal, with Fever-Tree receiving royalty fees based on its share of the profit generated in the US (with minimum payments guaranteed for five years).
Evercore ISI lowered the firm’s price target on Molson Coors (TAP) to $60 from $68 and keeps an Outperform rating on the shares ahead of the ...
This was the stock's second consecutive day of gains.
Berenberg raised the firm’s price target on Fevertree Drinks (FQVTF) to 860 GBp from 700 GBp and keeps a Hold rating on the shares.Maximize ...